End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.95 TWD | +2.92% | -10.06% | 0.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ling Mei Wang
CEO | Chief Executive Officer | - | 18-11-25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Hung Yeh
BRD | Director/Board Member | 52 | 21-12-07 |
Cheng Chi Chiang
BRD | Director/Board Member | - | 20-09-14 |
Ling Mei Wang
CEO | Chief Executive Officer | - | 18-11-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,795,094 | 47,420,250 ( 84.99 %) | 0 | 84.99 % |
Company contact information
Steminent Biotherapeutics, Inc.
16 Wenhu Street Neihu District
114006, Taipei
+
http://www.steminent.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 50.09M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- 7729 Stock
- Company Steminent Biotherapeutics, Inc